SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-740791
Filing Date
2016-10-18
Accepted
2016-10-18 16:16:03
Documents
3
Period of Report
2016-10-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d271004d8k.htm 8-K 18993
2 EX-99.1 d271004dex991.htm EX-99.1 13232
3 GRAPHIC g271004g03w06.jpg GRAPHIC 3896
  Complete submission text file 0001193125-16-740791.txt   39277
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 161941027
SIC: 2834 Pharmaceutical Preparations